189 related articles for article (PubMed ID: 22755553)
1. Lipoprotein-associated phospholipase A2 level in patients with Behçet's disease.
Örem A; Yayli S; Arıca DA; Akcan B; Yücesan FB; Bahadir S
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e289-93. PubMed ID: 22755553
[TBL] [Abstract][Full Text] [Related]
2. Increased advanced oxidation protein products in Behçet's disease: a new activity marker?
Yazici C; Köse K; Caliş M; DemIr M; Kirnap M; Ateş F
Br J Dermatol; 2004 Jul; 151(1):105-11. PubMed ID: 15270878
[TBL] [Abstract][Full Text] [Related]
3. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
4. Serum endocan levels as a marker of disease activity in patients with Behçet disease.
Balta I; Balta S; Koryurek OM; Demirkol S; Mikhailidis DP; Celik T; Cakar M; Kucuk U; Eksioglu M; Kurt YG
J Am Acad Dermatol; 2014 Feb; 70(2):291-6. PubMed ID: 24176522
[TBL] [Abstract][Full Text] [Related]
5. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum interleukin-8 levels in patients with Behcet's disease: high levels may indicate vascular involvement.
Durmazlar SP; Ulkar GB; Eskioglu F; Tatlican S; Mert A; Akgul A
Int J Dermatol; 2009 Mar; 48(3):259-64. PubMed ID: 19261013
[TBL] [Abstract][Full Text] [Related]
7. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
[TBL] [Abstract][Full Text] [Related]
8. Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome.
Liu S; Ren J; Xia Q; Wu X; Han G; Ren H; Yan D; Wang G; Gu G; Li J
Am J Med Sci; 2013 Dec; 346(6):467-72. PubMed ID: 23689052
[TBL] [Abstract][Full Text] [Related]
9. Circulating lipoprotein-associated phospholipase A2 in high-grade carotid stenosis: a new biomarker for predicting unstable plaque.
Sarlon-Bartoli G; Boudes A; Buffat C; Bartoli MA; Piercecchi-Marti MD; Sarlon E; Arnaud L; Bennis Y; Thevenin B; Squarcioni C; Nicoli F; Dignat-George F; Sabatier F; Magnan PE;
Eur J Vasc Endovasc Surg; 2012 Feb; 43(2):154-9. PubMed ID: 22075154
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.
Jabor B; Choi H; Ruel I; Hafiane A; Mourad W; Genest J
Can J Cardiol; 2013 Dec; 29(12):1679-86. PubMed ID: 24267807
[TBL] [Abstract][Full Text] [Related]
11. Phospholipase A2 in patients with noncardioembolic ischemic stroke and severe inflammatory reaction.
Cojocaru IM; Cojocaru M; Tănăsescu R; Iliescu I; Dumitrescu L; Burcin C; Gurban CV; Sfrijan F
Rom J Intern Med; 2009; 47(1):61-5. PubMed ID: 19886071
[TBL] [Abstract][Full Text] [Related]
12. [The correlation of human serum Lp-PLA2 and hs-CRP and stability of coronary atherosclerotic plaques].
Xu DL; Liu JN; Du YM; Yao GH; Jiang WD; Wang X; Dong ZQ; Hao L; Wang GY; Sui SJ; Li JF; Lu QH
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):651-4. PubMed ID: 19954057
[TBL] [Abstract][Full Text] [Related]
13. Prognostic utility of lipoprotein-associated phospholipase A2 for cardiovascular outcomes in patients with stable coronary artery disease.
Sabatine MS; Morrow DA; O'Donoghue M; Jablonksi KA; Rice MM; Solomon S; Rosenberg Y; Domanski MJ; Hsia J;
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2463-9. PubMed ID: 17766330
[TBL] [Abstract][Full Text] [Related]
14. Peripheral insulin resistance in patients with Behçet's disease.
Erdem H; Dinc A; Pay S; Simsek I; Turan M
J Eur Acad Dermatol Venereol; 2006 Apr; 20(4):391-5. PubMed ID: 16643134
[TBL] [Abstract][Full Text] [Related]
15. The relationship between serum prolactin levels and disease activity in patients with Behcet's disease.
Atasoy M; Karatay S; Yildirim K; Kadi M; Erdem T; Senel K
Cell Biochem Funct; 2006; 24(4):353-6. PubMed ID: 15898123
[TBL] [Abstract][Full Text] [Related]
16. Higher lipoprotein-associated phospholipase A2 levels are associated with coronary atherosclerosis documented by coronary angiography.
Dohi T; Miyauchi K; Ohkawa R; Nakamura K; Thuboi S; Ogita M; Miyazaki T; Nishino A; Yokoyama K; Kurata T; Yatomi Y; Daida H
Ann Clin Biochem; 2012 Nov; 49(Pt 6):527-33. PubMed ID: 22933444
[TBL] [Abstract][Full Text] [Related]
17. [Association of lipoprotein-associated phospholipase activity A2 with cardiovascular risk factors].
Acevedo M; Varleta P; Kramer V; Quiroga T; Prieto C; Parada J; Adasme M; Briones L; Navarrete C
Rev Med Chil; 2013 Nov; 141(11):1382-8. PubMed ID: 24718463
[TBL] [Abstract][Full Text] [Related]
18. Adenosine deaminase enzyme levels, their relation with disease activity, and the effect of colchicine on adenosine deaminase levels in patients with Behçet's disease.
Calis M; Ates F; Yazici C; Kose K; Kirnap M; Demir M; Borlu M; Evereklioglu C
Rheumatol Int; 2005 Aug; 25(6):452-6. PubMed ID: 15868151
[TBL] [Abstract][Full Text] [Related]
19. Utility of lipoprotein-associated phospholipase A2 for prediction of 30-day major adverse coronary event in patients with the first anterior ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention.
Stankovic S; Asanin M; Trifunovic D; Majkic-Singh N; Miljković A; Ignjatovic S; Mrdovic I; Matic D; Savic L; Ostojic M; Vasiljevic Z
Clin Lab; 2012; 58(11-12):1135-44. PubMed ID: 23289182
[TBL] [Abstract][Full Text] [Related]
20. Adiponectin levels, insulin resistance and their relationship with serum levels of inflammatory cytokines in patients with Behçet's disease.
Şahin E; Karaman G; Uslu M; Karul A; Şendur N; Şavk E
J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1498-502. PubMed ID: 22035239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]